Ansun Biopharma
Yi Shi, Ph.D. has served as Director of Ansun since April 2018. He is the Founder and Managing Partner of Lilly Asia Ventures, a biomedical venture capital firm with a focus on China and cross-border opportunities. Prior to his current role, Yi worked at Eli Lilly and Company in business development licensing and corporate ventures. His education includes a Ph.D. in Biochemistry and a Master of Business Administration, both from Duke University. He also has a Bachelor of Sciences in Biology from the University of Science and Technology of China.
This person is not in the org chart
This person is not in any offices
Ansun Biopharma
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics.